Clinical Trials Browser

Phase 1 × ficlatuzumab × Head & Neck × Clear all

NCT02277197 2019-04-18

Ficlatuzumab and Cetuximab in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC)

Phase 1 Completed

Squamous Cell Carcinoma of Head and Neck

NCT02277184 2017-11-13

Ficlatuzumab, Cisplatin and IMRT in Locally Advanced Head and Neck Squamous Cell Carcinoma

Phase 1 Terminated

Squamous Cell Carcinoma of Head and Neck, Carcinoma